Global Exporter & Bulk Supplier of Dactolieva 0.5 mg Injection

🌍 Introduction

Are you seeking a highly reliable and globally compliant exporter for Dactolieva 0.5 mg Injection? At Ernest Oncology (a premier division of Ernest Pharmaceutical Pvt. Ltd.), we specialize in the secure, temperature-controlled, and efficient distribution of essential cytotoxic therapeutics. We are a leading supplier of Dactinomycin 0.5 mg injections to specialty hospitals and pharmaceutical wholesalers across the USA, UK, Australia, and South Africa.

🔬 1. Product Overview: Dactolieva 0.5 mg Injection

Dactolieva 0.5 mg Injection contains Dactinomycin (also known as Actinomycin D), a potent antibiotic antineoplastic agent derived from Streptomyces parvullus.

• Composition: Dactinomycin 0.5 mg (as a sterile lyophilized powder)

• Therapeutic Class: Antitumor Antibiotic / Cytotoxic Agent

• Formulation Type: Single-dose vial for Intravenous (IV) administration.

• Storage: Store at controlled room temperature ($15^\circ\text{C}$ to $30^\circ\text{C}$); protect from light.

⚙️ 2. Mechanism of Action

Dactolieva works by binding directly to the DNA structure of malignant cells:

• DNA Intercalation: The Dactinomycin molecule intercalates (inserts itself) between adjacent guanine-cytosine base pairs of the DNA double helix.

• RNA Synthesis Inhibition: This binding creates a stable complex that inhibits the activity of RNA polymerase, effectively blocking the synthesis of messenger RNA (mRNA).

• Protein Synthesis Blockade: By halting RNA transcription, the cell is unable to produce the proteins necessary for survival and division, leading to cell death.

🏥 3. Therapeutic Indications

Dactolieva 0.5 mg Injection is a critical component in various pediatric and adult oncology protocols:

• Wilms' Tumor: A cornerstone treatment for this common pediatric kidney cancer.

• Rhabdomyosarcoma: Used in combination regimens for soft tissue sarcomas in children.

• Ewing's Sarcoma: Integrated into intensive multi-agent chemotherapy cycles.

• Gestational Trophoblastic Neoplasia: Effective in treating choriocarcinoma and related molar pregnancies.

• Testicular Cancer: Utilized in specific salvage or combination protocols.

⚠️ 4. Administration & Safety Guidelines

• Professional Use Only: Must be administered only by healthcare professionals experienced in handling potent cytotoxic agents.

• Vesicant Warning: Dactinomycin is a severe vesicant; extreme caution is required to prevent extravasation, which can cause severe tissue necrosis.

• Hematologic Monitoring: Regular monitoring of complete blood counts (CBC) and liver function is mandatory due to potential bone marrow suppression.

• Side Effects: Common reactions include nausea, vomiting, mouth sores (stomatitis), and hair loss (alopecia).